News

In an exclusive interview with Fox News Digital, Candace Cameron Bure got candid about the "scary" way certain fads are ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...
A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
Weight loss drugs are being hailed as revolutionary tools in the fight against obesity. Originally developed for diabetes, these drugs have gone mainstream - recommended by doctors, and sought after ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...